Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Endocr Relat Cancer. 2014 Dec 19;22(1):47–54. doi: 10.1530/ERC-14-0465

Table 1.

Variants found in 92 healthy controls

Chrom X Position (in hg19) DNA change# protein change exon SNP ID Domains in silico modeling prediction
SIFT Polyphen Align-GVGD
130,420,579 c.70C>T p.R24W 2 COSM1465661 signal peptide tolerated benign probably damaging
130,419,882 c.238A>G p.I80V 4 Novel - x - tolerated benign benign
130,419,793 c.327G>T p.W109C 4 Novel - x - tolerated probably damaging probably damaging
130,417,192 c.714G>A p.M238I 6 Novel - x - tolerated benign benign
130,412,680 c.1811A>C p.N604T 12 rs146462069 CTC tolerated probably damaging possibly damaging
130,412,680 c.1811A>C p.N604T 12 rs146462069 CTC tolerated probably damaging possibly damaging
130,412,078 c.2091dupC p.Thr698Hisfs*24 13 Novel CTC
130,412,018 c.2147G>A p.G716E 13 Novel CTC tolerated benign probably damaging
130,408,107 c.3844delC p.V1282X 19 Novel CTC

CTD: C-terminal domain;

#

All DNA changes were found in females in heterozygosity; GVGD Grantham variation / Grantham deviation